Atlas Trials

Viatris Innovation GmbH

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Viatris Innovation GmbH

RecordFirmDate
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment (NCT07201129)Viatris Innovation GmbH2026-02-09
A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants (NCT07301723)Viatris Innovation GmbH2025-12-11
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants (NCT07133191)Viatris Innovation GmbH2025-10-07
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus (NCT06475742)Viatris Innovation GmbH2024-07-30
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus (NCT05672576)Viatris Innovation GmbH2023-06-26
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (NCT05648500)Viatris Innovation GmbH2022-12-13
The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics (NCT05004311)Viatris Innovation GmbH2021-09-27
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod (NCT04819464)Viatris Innovation GmbH2021-08-25
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction (NCT04957719)Viatris Innovation GmbH2021-08-14
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects (NCT04557280)Viatris Innovation GmbH2020-11-06
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics (NCT04406896)Viatris Innovation GmbH2020-07-22
To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men. (NCT04255277)Viatris Innovation GmbH2020-01-31
Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects (NCT04052360)Viatris Innovation GmbH2019-08-07
A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects (NCT03814200)Viatris Innovation GmbH2019-01-03
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus (NCT03742037)Viatris Innovation GmbH2018-12-21
A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects (NCT03593278)Viatris Innovation GmbH2018-07-27
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease (NCT03384966)Viatris Innovation GmbH2018-01-24

Track Viatris Innovation GmbH automatically

Every clearance here is in the API, with alerts when new ones post.